Reserpine has displayed a capacity to inhibit the transport of biogenic amines into synaptic vesicles and adrenal chromaffin granules. The mechanism behind this inhibition has been illuminated as an irreversible binding to the vesicular amine transporter. Furthermore, Reserpine has been reported to interfere with dopamine transporter activity and potently inhibit synaptosomal dopamine uptake. Reserpine is an inhibitor of VMAT 2.
1. Schuldiner, S., et al. 1993. J. Biol. Chem. 268: 29-34. PMID: 8416935
2. Heslop, K.E., et al. 1999. Neuropharmacology. 38: 883-891. PMID: 10465692
3. Metzger, R.R., et al. 2002. Eur. J. Pharmacol. 456: 39-43. PMID: 12450567